LAMTOR5 and prostate cancer: WAC-AS1 was identified as a protective lncRNA in glioma [34], and LAMTOR5-AS1 was positively correlated with less aggressive prostate cancer [35]; their prognostic indications matched our discoveries, while there have been no reports concerning TRAM2-AS1, FOXN3-AS1, and ARHGAP26-AS1 in cancer studies.